The U.S. Allergy Immunotherapy Market Size is Anticipated to Exceed USD 680 Million by 2033, growing at a CAGR of 10.39% from 2023 to 2033.
Allergy immunotherapy involves repeated exposure to allergens to reduce IgE-mediated reactions from triggers like mites and pollen. With rising allergy cases in the U.S., where 25.7% of adults had seasonal allergies in 2021, the demand for...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian